menu
    • menu

    Company profile for Quince Therapeutics

    NEW Drugs in Dev: 8
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Quince Therapeutics is focused on advancing innovative precision therapeutics targeting debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote more rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Quince’s discov...
    Quince Therapeutics is focused on advancing innovative precision therapeutics targeting debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote more rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Quince’s discovery pipeline is positioned for rapid expansion across multiple skeletal therapeutic indications to address underserved therapeutic areas.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Quince TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    601 Gateway Blvd, Suite 1250, South San Francisco, California 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://quincetx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/quincetx-inc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Paris Packaging Week

    Paris Packaging Week

    Not Confirmed

    envelop Contact Supplier

    Paris Packaging Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Quince Reports Positive Ph 3 eDSP Data in Ataxia-Telangiectasia
    Quince Reports Positive Ph 3 eDSP Data in Ataxia-Telangiectasia

    29 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260129349326/en/Quince-Therapeutics-Announces-Topline-Results-from-Pivotal-Phase-3-NEAT-Clinical-Trial-of-eDSP-in-Ataxia-Telangiectasia

    BUSINESSWIRE
    29 Jan 2026
    Share Share
    Quince Therapeutics Reveals Long-Term eDSP Safety Data
    Quince Therapeutics Reveals Long-Term eDSP Safety Data

    28 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260128605412/en/Quince-Therapeutics-Presents-Safety-Data-from-Long-Term-eDSP-Treatment-in-Children-with-Ataxia-Telangiectasia-at-British-Paediatric-Neurology-Association-Annual-Meeting

    BUSINESSWIRE
    28 Jan 2026
    Share Share
    Quince Therapeutics Completes Phase 3 NEAT Trial
    Quince Therapeutics Completes Phase 3 NEAT Trial

    15 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251215328276/en/Quince-Therapeutics-Announces-Last-Patient-Last-Visit-in-Phase-3-NEAT-Clinical-Trial-in-Patients-with-Ataxia-Telangiectasia

    BUSINESSWIRE
    15 Dec 2025
    Share Share
    Quince Therapeutics Publishes Edsp Use In Early Clinical Studies
    Quince Therapeutics Publishes Edsp Use In Early Clinical Studies

    10 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251210188416/en/Quince-Therapeutics-Announces-Publication-of-Use-of-eDSP-in-Early-Stage-Clinical-Studies-in-Pulmonary-and-Inflammatory-Bowel-Disorders

    BUSINESSWIRE
    10 Dec 2025
    Share Share
    Quince Therapeutics To Join Investor Events In Dec 2025
    Quince Therapeutics To Join Investor Events In Dec 2025

    24 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251124942104/en/Quince-Therapeutics-to-Participate-at-Investor-Events-in-December-2025

    BUSINESSWIRE
    24 Nov 2025
    Share Share
    Quince Therapeutics Updates Business & Reveals Q3 2025 Result
    Quince Therapeutics Updates Business & Reveals Q3 2025 Result

    12 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251112266523/en/Quince-Therapeutics-Provides-Business-Update-and-Reports-Third-Quarter-2025-Financial-Results

    BUSINESSWIRE
    12 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search